Outset Medical, Inc. (NASDAQ:OM) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET

Company Participants

Jim Mazzola - Vice President, Investor Relations

Leslie Trigg - Chair & Chief Executive Officer

Nabeel Ahmed - Chief Financial Officer

Conference Call Participants

Travis Steed - Bank of America Securities

Rick Wise - Stifel

Shagun Singh - RBC Capital Markets

Suraj Kalia - Oppenheimer & Company

Josh Jennings - TD Cowen

Drew Ranieri - Morgan Stanley

Operator

Good day, and thank you for standing-by. Welcome to Outset Medical Q2 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advice that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Jim Mazzola. Please go ahead. Jim, if you could go ahead and unmute yourself please.

Jim Mazzola

Okay. Good afternoon, everyone, and welcome to our second quarter 2023 earnings call. Here with me today are Leslie Trigg, Chair and Chief Executive Officer; and Nabeel Ahmed, Chief Financial Officer.

During the call, we will discuss our second quarter 2023 operational and financial results and host a question-and-answer session. We issued a news release after the close of market today and updated our investor presentation, both of which can be found on the Investor Relations pages of outsetmedical.com. This call is being recorded and will be archived in the Investors section of our website.

It is our intent that all forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. These statements relate to expectations or predictions of future events, are based on our current estimates and various assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied. Outset assumes no obligation to update these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section about the public filings with the Securities and Exchange Commission, including our latest annual and quarterly reports.

With that, I will now turn the call over to Leslie.

Leslie Trigg

Thanks, Jim. Good afternoon, everyone, and thank you for joining us. We are pleased to share our second quarter 2023 results, which were marked by accelerating quarter-over-quarter revenue growth, further margin expansion and continued commercial traction across our business.